Local Low-dose Anti-PD-L1 Antibodies Improve Antitumor Effects in Oral Squamous Cell Carcinoma. Machida T, Sakuma K, Fuwa N, Tanaka A, et al. Anticancer Res 2024;44:993-1002.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Machida T, Sakuma K, Fuwa N, Tanaka A, et al. Local Low-dose Anti-PD-L1 Antibodies Improve Antitumor Effects in Oral Squamous Cell Carcinoma. Anticancer Res 2024;44:993-1002.
PMID: 38423636